Striving to modernize the way it regulates clinical trials, FDA is holding a two-day public hearing to get guidance from stakeholders on what it can do to foster efficiency and innovation.
The meeting, which was announced in a March 7 Federal Register notice
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?